Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.41 |
| ▸ | HPGDS | O60760 | 4/20 | 0.40 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.40 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.39 |
| ▸ | MLLT1 | Q03111 | 1/20 | 0.38 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.36 |
| ▸ | GAPDH | P04406 | 1/20 | 0.36 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7539053 | 0.82 | CA12 (0.41) | — | |
| SCHEMBL11133836 | 0.81 | AKR1C3 (0.47) | AKR1C3AKR1C2HPGDSBAZ2BBAZ2A | |
| SCHEMBL4750120 | 0.78 | DHODH (0.44) | FFAR1 | |
| SCHEMBL7535243 | 0.78 | GABRA1 (0.40) | ADRA2AADRA2BADRA2CBAZ2BBAZ2A | |
| SCHEMBL7743329 | 0.77 | ADRB1 (0.46) | AKR1C3AKR1C2ADRA2AADRA2BADRA2C | |
| SCHEMBL10094321 | 0.77 | HSD17B1 (0.47) | AKR1C3AKR1C2ADRA2AADRA2BADRA2C | |
| SCHEMBL28472426 | 0.77 | AKR1C3 (0.58) | AKR1C3AKR1C2ADRA2BBAZ2BBAZ2A | |
| Hydrochloric Acid SCHEMBL7743489 | 0.76 | ADRB1 (0.45) | AKR1C3AKR1C2ADRA2AADRA2BADRA2C | |
| SCHEMBL28673920 | 0.75 | ALDH1A1 (0.42) | — | |
| SCHEMBL3715003 | 0.74 | ADRB1 (0.50) | ADRA2AADRA2BADRA2CHPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008123821-A1 | 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS | ALBIREO AB (SE) | 2008-10-16 | — | — | WO | disclosed |